Researchers had proved that KIF2A served as an oncogene in a series of tumors, such as nasopharyngeal carcinoma [22], lung adenocarcinoma [43], gastric cancer [44], and glioma [45]. Here, KIF2A is linked to nasopharyngeal carcinoma.